Teva ADR earnings beat, Revenue misses in Q1

  • Investing.com
Teva ADR earnings beat, Revenue misses in Q1

Investing.com - Teva ADR reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.

Teva ADR announced earnings per share of $0.63 on revenue of $4B. Analysts polled by Investing.com anticipated EPS of $0.5878 on revenue of $4.01B.

Teva ADR shares are up 7.46% from the beginning of the year and are trading at $10.37 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% year to date.

Teva ADR follows other major Healthcare sector earnings this month

Teva ADR's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.

Abbott Labs had beat expectations on Tuesday, April 20, 2021 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles